U.S. Trade Distributors Stock News

Novavax presented its licensing-led vaccine and adjuvant strategy at Cantor Fitzgerald's Global Healthcare Conference and Citi's Biopharma Back to School Summit in New York, outlining how partners such as Sanofi and Pfizer are involved in commercialization and development plans. Management highlighted that upfront payments, milestones and technology transfers tied to Matrix-M partnerships are increasingly central to funding research, including early oncology work on "cold" tumors. We will...

A 1.4% pop in Adobe on Friday is a polite clap, not a standing ovation, for what just landed. Traders nudged the stock higher while the actual report shouted something louder. Q3 revenue reached US$6.76b and non GAAP earnings per share came in at US$6.13, both solid for a mature software heavyweight. Yet the real story sat in fast building recurring cash flows. Annualized recurring revenue hit US$27.5b, a figure that speaks directly to durability, even if the short term price move suggests...

Atkore has delivered a strong 56.7% return over the past year, yet valuation checks suggest the stock now trades close to its estimated intrinsic value rather than offering obvious cheapness. The 1 year gain of 56.7% sets a high bar for fresh buyers who are weighing how much of Atkore’s cash flow story is already reflected in the price. Future cash generation from its electrical and infrastructure products can support the current share price, while any pressure on volumes or pricing could...

Hewlett Packard Enterprise stock has logged a very strong five year run, yet both an intrinsic value check and earnings multiples still point to the shares pricing in less than the modelled worth of the business. That mix of a big past gain and lingering valuation gap is what investors now need to weigh. Over the past five years, Hewlett Packard Enterprise has returned about 423.4%, which is a very large gain and sets a high bar for any further upside to feel justified. Heavy demand for...

SoundHound AI (NasdaqGM:SOUN) has appointed former LivePerson chief John Collins as chief financial officer of the combined company. Collins previously served as LivePerson's CFO and interim CEO during the period leading up to SoundHound AI's acquisition of the business. The finance chief is expected to oversee integration of LivePerson's operations and support SoundHound AI's push toward profitability in AI customer service. The Collins CFO appointment after the LivePerson acquisition is...

Designer Brands stock slipped 1.8% to US$5.88 after the earnings release, which might look like a shrug from the market, yet the quarter told a sharper story. This is a retailer often viewed as a low-growth mall staple, but Q2 showed a different picture with adjusted gross margin at 47.9% and adjusted operating income at US$39.4m. The big swing factor was profit quality. A US$20.2m tariff refund lifted results, while underlying assortment and inventory choices did some of the heavy lifting on...

SK hynix (NasdaqGS:SKHY) is back in focus after South Korea’s KOSPI index saw sharp swings this year, with chip heavyweights like SK hynix cited as key drivers of that volatility. Recent moves in SK hynix share price tell a different story from the choppy KOSPI. The stock posted a 1-day share price return of 0.94%, a 7-day share price return of 7.38%, and a punchy 30-day share price return of 23.09%. A 13.13% year to date share price return suggests momentum has been building as investors...

Burning Rock Biotech rose 5.7% today, extending a sharp three-month rally, even though the latest quarter still shows the business firmly in loss-making territory. Traders are reacting to improving top-line scale rather than clean profitability. Revenue for Q2 was ¥134.8m, while the company reported a net loss of ¥18.4m and a basic loss per share of ¥1.70. For anyone looking beyond the next few sessions, the focus is on whether that growing sales base, together with a P/S of 1.8x against far...

Goodyear Tire & Rubber stock has had a rough run over the past few years, yet its current valuation checks still flag it as looking cheap on several fronts. For investors watching a long slide in the share price, the question is whether that discount reflects opportunity or simply the heavy baggage of a highly leveraged, low margin business trying to repair itself. Over the past 5 years, Goodyear Tire & Rubber has declined 68.4%, which signals that the market has significantly marked down...

Star Bulk Carriers has delivered strong share price gains over the past few years, yet the valuation picture today is more nuanced than a simple "cheap" or "expensive" label. The stock screens as undervalued on market multiples, while a mixed overall value score suggests investors need to look closely at what is really priced in. Over the past 5 years, Star Bulk Carriers has returned about 141%, which puts extra weight on whether recent enthusiasm has already captured much of the easy...

Expand Energy stock has nearly doubled over the past five years, yet the broader valuation checks still point to a company that looks cheap rather than fully priced in. Recent share price softness contrasts with a high value score and an undervalued read on market multiples, which puts the current level under closer scrutiny for long term investors. Expand Energy has returned about 96% over five years, which suggests long term holders have already seen solid gains even as the recent trend...

Vail Resorts reported that, after the close of its nomination window, activist investor Oasis Management and other shareholders submitted slates to nominate Robert A. Chapek, M. Ashton Hudson, Bryce Roberts, and Picabo Street for board seats. The company is also conducting a separate search for an additional independent director into early 2027. The contest over board seats highlights how Vail Resorts’ governance is being challenged at the same time the business faces less predictable...

Gilead Sciences (GILD) just saw its herpes simplex virus collaboration with Assembly Biosciences deepen, as Assembly opted into a 40% U.S. cost and profit share on the HSV helicase primase program. The Gilead Sciences share price has climbed 18.19% year to date and 14.44% over the past 90 days, while the 1-year total shareholder return of 28.73% and 3-year total shareholder return above 2x suggest momentum has been building as investors weigh recent product approvals, legal wins and expanded...

XPeng (NYSE:XPEV) reported August 2026 vehicle deliveries of 39,107 units, a 4% year over year increase, giving investors fresh data on how the physical AI focused automaker is converting interest into actual sales. The fresh delivery update comes amid a weak price backdrop for XPeng, with the share price down 10.3% over the past 30 days and 48.4% year to date, while the 1-year total shareholder return has declined 49.5%. This signals that recent momentum has been fading despite improving...

MannKind stock has fallen about 33% year to date, yet several valuation checks, including an intrinsic value estimate using a Discounted Cash Flow (DCF) approach, point to a price that sits below what those models suggest. That gap, combined with mixed signals from broader valuation screens, puts the current share level under closer scrutiny for investors trying to assess what is already priced in. The share price has declined roughly 33% year to date, which means sentiment has cooled...

Amgen (NasdaqGS:AMGN) reported Phase 3 DeLLphi-305 results for IMDELLTRA in first-line maintenance extensive stage small cell lung cancer. The study is described as the first Phase 3 trial to show an overall survival benefit for a BiTE therapy in this setting. Management positioned the positive DeLLphi-305 outcome as a key milestone for Amgen's oncology franchise and treatment options in small cell lung cancer. The DeLLphi-305 survival data for IMDELLTRA adds fresh context to the broader...

The market barely flinched on Yuanbao, with the stock up just 2% today, yet the earnings story was far louder than the price move suggests. You saw a routine green day. The company printed a sharp Q2 headline, with revenue of RMB 1.39b and net income of RMB 413.2m. That left a net margin of 29.7%, a powerful figure for an online insurance platform. In the short term, the share price reaction looks cautious. The gap between that restraint and the strength of the profitability trend is where...

A new global carbon fiber report has put Hexcel (HXL) in focus, naming the producer among leading suppliers to aerospace, wind energy, electric vehicles, hydrogen storage, and recycled carbon markets. Hexcel shares closed at US$92.74 after a 3.25% 1-day share price return, while the stock is still down 9.35% on a 30-day share price basis and 5.09% over 90 days. The 1-year total shareholder return of 50.93% and 5-year total shareholder return of 66.02% indicate momentum that has built over a...

Bilibili (BILI) has completed a zero coupon, callable and convertible Eurobond offering of US$700 million in senior unsecured notes due September 15, 2031, adding Goldman Sachs and Morgan Stanley Asia as co-lead underwriters. Bilibili’s share price has been weak this year, with the stock down 41.07% year to date and a 30 day share price return of 11.75% in decline, even though the 3 year total shareholder return of 12.61% hints at patchy but not uniform long term momentum. Scan beyond...

Strategy stock has delivered a very strong 3 year gain while the broader valuation checks still lean expensive, leaving recent buyers weighing momentum against what the numbers are saying about value today. Over the past 3 years, Strategy has returned about 2.8x, which puts recent share price weakness into the context of a very large multi year run. Management’s renewed commitment to Bitcoin accumulation and the creation of DeFi yield products tied to its preferred stock can support the...

T-Mobile US (TMUS) just tied its latest iPhone 18 lineup launch to aggressive trade in credits, extended 36 month financing and new iPhone Handoff features. This gives investors fresh data on the company’s device driven customer acquisition approach. T-Mobile US has had a choppy run into this iPhone 18 campaign, with the share price up 2.92% on the day to US$182.33 yet still recording a year to date share price return that is down 8.64% and a 1 year total shareholder return that is down...

TraceLink announced that its DSCSA compliance platform has been integrated into Omnicell’s central pharmacy inventory systems, allowing hospital pharmacies to handle product verification, traceability, and audit-ready reporting directly within existing medication receiving workflows. This tie-up plugs Omnicell customers into TraceLink’s large authenticated supply chain network, which may ease compliance workloads for hospital teams already facing operational and cost pressure. Next, the...

Campbell's stock has retreated sharply over the past few years, yet some of the current valuation checks still view the shares as not outright expensive or cheap. Recent cost cuts, a reduced dividend and weaker profitability now sit against a mixed read on value rather than a clear bargain. The share price has fallen 44.2% over the past three years, which signals that investors have been marking down expectations for the business. A planned US$500m cost reduction program can support margins...

Kaspi.kz (KSPI) has approved a KZT 1,000 dividend per common share for the second quarter of 2026 at its Extraordinary General Meeting, with payments scheduled to begin on 9 September 2026. Kaspi.kz shares closed at $99.96 on 10 September, with a 1 day share price return of 2.89% after the dividend news, while the 90 day share price return of 24.08% and 1 year total shareholder return of 26.30% indicate that momentum has been building rather than fading. Scan other dividend heavyweights with...